The Pipeline Café features academic innovators who are hand selected to present their discoveries, which are available for partnering, in two poster sessions. The academic innovators will be available for discussions at their posters as well as one-on-one partnering meetings.
2017 Pipeline Cafe Participants:
A platform for developing drug and cell-based therapeutics targeting fat metabolism for treatment of obesity and metabolic disease
Brian Gillette, PhD, Co-Founder, Director, Ardent Cell Technologies
Enhancing the Immune System during Cancer Therapy
Cynthia L. Bristow, PhD, Chief Executive Officer, Alpha-1 Biologics
Fighting blindness with polymeric nanotechnology for ocular biologics delivery
Brian W. Pan, CEO, BioHealthWays, Inc.
Therapeutic development of miR-129 mimic for metastatic colorectal cancer
Jingfang Ju, PhD, Founder, CurMiR; Professor, Pathology, Stony Brook University
The development of a rapid and highly-efficiency platform for isolating human antibodies to treat infectious diseases
Raymond A. Alvarez, PhD, Co-founder & CEO, Ichor Biologics
Non-Invasive In Vivo Optical Detection of Lipid Accumulation for NAFLD Drug Discovery
Prakrit V. Jena, PhD, CEO, LipidSense
Novel bacteria-based immunotherapeutic strategies for the treatment of cancer
Boris Shor, PhD, Founder & CEO, Manhattan BioSolutions
MouSensor: Super sniffer mice to digitize the sense of smell
Charlotte D’Hulst, PhD, Co-Founder & Yukie Takabatake, PhD, Scientist, MouSensor, LLC
Development of Targeted Delivery of β-Catenin Agonists for Non-union Fracture Healing
Seth Harlem, CEO, Taithera, Inc.
Widening The Therapeutic Window: Time-dependent Inhibitors of LpxC For Treating MDR Gram Negative Bacterial Infections
Peter Tonge, PhD, CSO, Chronus Pharmaceuticals; Director, Infectious Disease Research, Institute for Chemical Biology and Drug Discovery & Fereidoon Daryaee, PhD, Postdoctoral Associate, Chemistry, Stony Brook University
a Novel PET Radiotracer for Imaging Bacterial Infection
Peter Tonge, PhD, CSO, Chronus Pharmaceuticals; Director, Infectious Disease Research, Institute for Chemical Biology and Drug Discovery & Yong Li, PhD Candidate, Chemistry, Stony Brook University